Hiroki Morishita

Chuo, 2608670, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation.

Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation.

Journal: Transplant immunology
Published: February 24, 2026

Clinical Significance of Molar Count in Esophageal Squamous Cell Carcinoma: Propensity Score Matching Study.

Clinical Significance of Molar Count in Esophageal Squamous Cell Carcinoma: Propensity Score Matching Study.

Journal: Anticancer research
Published: July 07, 2025

Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma.

Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma.

Journal: Oncology
Published: December 04, 2024

High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.

High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Journal: Oncology
Published: November 04, 2024

Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma.

Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma.

Journal: Cancer diagnosis & prognosis
Published: August 15, 2024

High Subcutaneous Adipose Tissue Radiodensity Predicts Poor Prognosis in Patients With Gastric Cancer.

High Subcutaneous Adipose Tissue Radiodensity Predicts Poor Prognosis in Patients With Gastric Cancer.

Journal: Cancer diagnosis & prognosis
Published: July 26, 2024

Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.

Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.

Journal: Cancer medicine
Published: April 26, 2024

SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

Journal: Oncology
Published: April 15, 2024

Establishment of a novel small bowel adenocarcinoma cell line using patient‑derived xenografts, which produces CEA and CA19‑9.

Establishment of a novel small bowel adenocarcinoma cell line using patient‑derived xenografts, which produces CEA and CA19‑9.

Journal: Oncology letters
Published: March 29, 2024

A Case of Resection of Overlapping Ascending Colon Cancer and Primary Malignant Lymphoma of the Cecum

A Case of Resection of Overlapping Ascending Colon Cancer and Primary Malignant Lymphoma of the Cecum

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 02, 2024

A Case of Postoperative Lymph Node Metastatic Recurrence of Ascending Colon Cancer Invading the Primary Branch of Superior Mesenteric Artery during Hemodialysis

A Case of Postoperative Lymph Node Metastatic Recurrence of Ascending Colon Cancer Invading the Primary Branch of Superior Mesenteric Artery during Hemodialysis

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 02, 2024

Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis.

Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis.

Journal: Oncology letters
Published: January 18, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026